Brunner, F.S., Brown, M.R., Bassano, I., Denise, H., Khalifa, M.S., Wade, M.J., van Aerle, R., Kevill, J.L., Jones, D.L., Farkas, K., Jeffries, A.R., Cairns, E., Wierzbicki, C., Paterson, S., Bashton, Matthew, Smith, Darren, Nelson, Andrew, Young, Greg, McCann, Clare and The COVID-19 Genomics UK (COG-UK) Consortium, (2022) City-wide wastewater genomic surveillance through the successive emergence of SARS-CoV-2 Alpha and Delta variants. Water Research, 226. p. 119306. ISSN 0043-1354
|
Text
1-s2.0-S0043135422012519-main.pdf - Published Version Available under License Creative Commons Attribution 4.0. Download (3MB) | Preview |
Abstract
Genomic surveillance of SARS-CoV-2 has provided a critical evidence base for public health decisions throughout the pandemic. Sequencing data from clinical cases has helped to understand disease transmission and the spread of novel variants. Genomic wastewater surveillance can offer important, complementary information by providing frequency estimates of all variants circulating in a population without sampling biases. Here we show that genomic SARS-CoV-2 wastewater surveillance can detect fine-scale differences within urban centres, specifically within the city of Liverpool, UK, during the emergence of Alpha and Delta variants between November 2020 and June 2021. Furthermore, wastewater and clinical sequencing match well in the estimated timing of new variant rises and the first detection of a new variant in a given area may occur in either clinical or wastewater samples. The study's main limitation was sample quality when infection prevalence was low in spring 2021, resulting in a lower resolution of the rise of the Delta variant compared to the rise of the Alpha variant in the previous winter. The correspondence between wastewater and clinical variant frequencies demonstrates the reliability of wastewater surveillance. However, discrepancies in the first detection of the Alpha variant between the two approaches highlight that wastewater monitoring can also capture missing information, possibly resulting from asymptomatic cases or communities less engaged with testing programmes, as found by a simultaneous surge testing effort across the city.
Item Type: | Article |
---|---|
Additional Information: | Matthew Bashton, Andrew Nelson, Clare McCann, Greg Young and Darren Smith are members of the COVID-19 Genomics UK consortium. Funding was provided by NERC (NE/V003860/1) and DHSC UK (2020_097). This report is independent research funded by the Department of Health and Social Care. The views expressed in this publication are those of the authors and not necessarily those of the Department of Health and Social Care. COG-UK is supported by funding from the Medical Research Council (MRC) part of UK Research & Innovation (UKRI), the National Institute of Health Research (NIHR) [grant code:MC_PC_19027], and Genome Research Limited, operating as the Wellcome Sanger Institute. |
Uncontrolled Keywords: | Humans, Wastewater, SARS-CoV-2/genetics, Reproducibility of Results, COVID-19/epidemiology, Wastewater-Based Epidemiological Monitoring, Genomics |
Subjects: | A300 Clinical Medicine B200 Pharmacology, Toxicology and Pharmacy |
Department: | Faculties > Health and Life Sciences > Applied Sciences |
Depositing User: | Rachel Branson |
Date Deposited: | 22 Feb 2023 11:41 |
Last Modified: | 22 Feb 2023 11:45 |
URI: | https://nrl.northumbria.ac.uk/id/eprint/51472 |
Downloads
Downloads per month over past year